Expertise in
7
conditions

Christian Berthou

Brest, FR 
Expertise in
7
conditions
Brest, FR 

Overview

Christian Berthou practices practicing medicine in Brest, France.

Mr. Berthou is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Febrile Neutropenia, Agranulocytosis, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 79 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Brest, France
Other Locations
Nancy, France
Limoges, France
Bordeaux, France
Nantes, France
Lille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Identification of Genetic Factors Predisposing to Dysglobulinemia
Identification of Genetic Factors Predisposing to Dysglobulinemia
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Genetic
Study Phase: Not Applicable
A Randomized Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS With Non RBC Transfusion Dependent Anemia and Without Del 5q
A Randomized Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS With Non RBC Transfusion Dependent Anemia and Without Del 5q
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Drug
Study Drug: EPREX Erythropoietin
Study Phase: Phase 3
A Randomized Phase III Study of Decitabine (DAC) With or Without Hydroxyurea (HY) Versus HY in Patients With Advanced Proliferative Chronic Myelomonocytic Leukemia (CMML)
A Randomized Phase III Study of Decitabine (DAC) With or Without Hydroxyurea (HY) Versus HY in Patients With Advanced Proliferative Chronic Myelomonocytic Leukemia (CMML)
Enrollment Status: Completed
Publish Date: November 19, 2021
Intervention Type: Drug
Study Drugs: Decitabine, Hydroxyurea
Study Phase: Phase 3
View 2 Less Clinical Trials

79 Total Publications

18F-FDG PET radiomic analysis to predict outcomes in metastatic melanoma treated with immune checkpoint inhibitors.
18F-FDG PET radiomic analysis to predict outcomes in metastatic melanoma treated with immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: June 06, 2025

Frequently Asked Questions about Christian Berthou

Is Christian Berthou a top-rated expert for Febrile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Christian Berthou is classified as an Elite expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christian Berthou participate in research or clinical trials?

Yes. Christian Berthou has published 79 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Christian Berthou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Berthou's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile